000 01317 a2200385 4500
005 20250513223057.0
264 0 _c20001121
008 200011s 0 0 eng d
022 _a0003-4967
024 7 _a10.1136/ard.59.suppl_1.i85
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aBraun, J
245 0 0 _aTreatment of spondyloarthropathies with antibodies against tumour necrosis factor alpha: first clinical and laboratory experiences.
_h[electronic resource]
260 _bAnnals of the rheumatic diseases
_cNov 2000
300 _ai85-9 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAntibodies, Monoclonal
_xtherapeutic use
650 0 4 _aAntirheumatic Agents
_xtherapeutic use
650 0 4 _aHumans
650 0 4 _aSpondylitis
_xtherapy
650 0 4 _aTumor Necrosis Factor-alpha
_xantagonists & inhibitors
700 1 _aXiang, J
700 1 _aBrandt, J
700 1 _aMaetzel, H
700 1 _aHaibel, H
700 1 _aWu, P
700 1 _aKohler, S
700 1 _aRudwaleit, M
700 1 _aSiegert, S
700 1 _aRadbruch, A
700 1 _aThiel, A
700 1 _aSieper, J
773 0 _tAnnals of the rheumatic diseases
_gvol. 59 Suppl 1
_gp. i85-9
856 4 0 _uhttps://doi.org/10.1136/ard.59.suppl_1.i85
_zAvailable from publisher's website
999 _c10995880
_d10995880